red star capital bureau on February 18 news, a number of pharmaceutical listed company executives intensive resignation.

Red Star Capital Bureau has incomplete statistics. Since January (January 17-February 17), as many as 29 listed company executives have made personnel changes.

on January 18, Liu Yao group (603368.SH) announced that due to job changes, Chen hong applied to resign from the position of vice president of the company and still held the position of director of the company after resignation. On the same day, upon the nomination of the president of the company, it was agreed to appoint Liang Zhen as the vice president of the company.

On January 18, Northeast Pharmaceutical (000597.SZ) announced that Cai Yang applied to resign from the position of secretary of the company's board of directors due to personal reasons. After resignation, he will no longer hold any position in the company.

On January 18, Jincheng Pharmaceutical (300233.SZ) announced that the company's board of directors received a written resignation report submitted by director and vice president Fu Miaoqing. Fu Miaoqing applied to resign from the company's director, vice president and sixth board of directors due to personal reasons. After resigning, he still served as the chairman of the company's holding subsidiary Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. On the same day, the board of directors agreed to appoint Wang Hui and Zhang Xicheng as vice presidents of the company.

on January 19, pien Tze Huang (600436.SH) announced that Chen Jipeng resigned from the position of supervisor and chairman of the board of supervisors due to job adjustment. After his resignation, Chen Jipeng will no longer hold any position in the company.

on January 22, haizheng pharmaceutical (600267.SH) announced that Lu xinghai applied to resign as senior vice president of the company for personal reasons. Haizheng Pharmaceutical said the company would make separate arrangements for its work.

On January 23, Frontier Biology (688221.SH) announced that Wen Honghai resigned as a non-independent director of the company's third board of directors due to personal job changes, and at the same time resigned as a member of the audit committee of the third board of directors. After his resignation, Wen Honghai no longer holds any position in the company.

on January 27, guangji pharmaceutical (000952.SZ) announced that Hu mingfeng, director and chief financial officer of the company, applied to resign as chief financial officer of the company due to job changes. After his resignation, Mr. Hu Mingfeng continued to serve as a director of the company. On the same day, upon the nomination of the chairman of the board, it was agreed to appoint Xiong Yi as the company's chief financial officer.

on January 27, maide medical (688310.SH) announced that Wu Yifan resigned from the position of non independent director of the fourth board of directors of the company due to personal work arrangement. After Wu Yifan resigns from the above position, he will no longer hold any position in the company.

on January 30, Yifeng pharmacy (603939.SH) announced that Tian Wei applied to resign as vice president of the company for personal reasons. after resignation, he will no longer hold other positions in the company. On the same day, the company's president Gao Yi nominated, agreed to appoint Hu Jianxia as the company's assistant president.

on January 31, jindik (688670.SH) announced that fan changyong, deputy general manager and secretary of the board of directors of the company, resigned for personal reasons and would not work in the company after his resignation.

on February 1, meinian health (002044.SZ) announced that due to job adjustment, tan Xu applied to resign as a supervisor of the eighth board of supervisors of the company. After his resignation, Tan Xu no longer holds any position in the company.

on February 1, panlong pharmaceutical (002864.SZ) announced that due to work arrangements, Xie Xiaolin resigned as general manager of the company, and Zhang Zhihong and Wu Jie resigned as deputy general managers of the company. Zhang level resigned as a director of the company for personal reasons. The board of directors agreed to appoint Hu Qifei as the new general manager of the company.

On February 2, West Point Pharmaceutical (301130.SZ) announced that due to job changes, Meng Yonghong no longer served as the secretary of the company's board of directors, and continued to serve as the company's director and deputy general manager after leaving office.

On February 2, Tailong Pharmaceutical (600222.SH) announced that due to job adjustments, Feng Haiyan applied to resign from the position of secretary and deputy general manager of the company's board of directors. After his resignation, he will still hold other positions in the company. Upon the nomination of the chairman of the company, Li Nianyun was appointed as the secretary of the board of directors of the company.

on February 2, huada zhizao (688114.SH) announced that Fang Hao applied to resign as a non-independent director of the company for personal reasons and would no longer hold any position in the company after his resignation.

On February 3, Gongdong Medical (605369.SH) announced that due to personal reasons, Pan Lei applied to resign as the company's chief financial officer. After resigning as the chief financial officer, he will continue to hold other positions in the company. Prior to the appointment of a new CFO, the Company's director and general manager, Zhong Health, performed the duties of the CFO on his behalf.

on February 3, nuotai biology (688076.SH) announced that gu Haitao, deputy general manager and core technician of the company, and yang Jie, core technician, resigned for personal reasons and would no longer hold any position in the company after resignation. After the company's management research decision, the new identified Zhang Yu, Liu Ting as the company's core technical personnel.

on February 5, tongce medical (600763.SH) announced that Wang Shouyang, an independent director of the company, submitted a written resignation report for personal reasons and no longer held any position in the company.

on February 5, yaben chemical (300261.SZ) announced that Mao Haifeng applied to resign from the position of director and deputy general manager of the company for personal reasons. after his resignation, Mr. Mao Haifeng will continue to serve as the head of the company's supply chain center.

on February 5, hualan shares (301093.SZ) announced that jiao baoan plans to resign as head of the company's audit department from February 7, 2024 due to personal reasons, and will no longer hold any position in the company after resignation.

on February 5, hong kong tong medical (301515.SZ) announced that he George Xiaogang applied to resign as a director of the fourth board of directors of the company due to his busy work. after his resignation, he will no longer hold any position in the company.

On February 6, Kelaiying (002821.SZ) announced that due to personal reasons, Wang Qingsong requested to resign as an independent director of the company's fourth board of directors, chairman of the remuneration and assessment committee of the board of directors, member of the audit committee and nomination committee. Wang Qingsong no longer holds a position in the company after his resignation.

On February 6, Kangchen Pharmaceutical (603590.SH) announced that Zhou Jun applied to resign as a director of the company's fourth board of directors due to personal reasons. After resignation, he will no longer hold any position in the company.

On February 7, Yibai Pharmaceutical (600594.SH) announced that Lang Hongping applied to resign as vice chairman, director and co-president of the company for personal reasons. After his resignation, Mr. Lang Hongping no longer holds any position in the company.

On February 7, Mingde Biology (002932.SZ) announced that Xu Bo applied to resign from the position of the company's securities affairs representative for personal reasons, and Zhou Guohui applied to resign from the position of the company's financial director for personal reasons. After their resignation, they will no longer hold any positions in the company and its holding subsidiaries.

On February 8, Yunnan Baiyao (000538.SZ) announced that Yin Pinyao applied to resign from the company's chief operating officer, senior vice president and all positions in the company and its holding subsidiaries due to personal reasons; Yu Juan applied for personal reasons Resignation as the company's chief human resources officer and all positions in the company and its holding subsidiaries.

On February 8, Huaren Pharmaceutical (300110.SZ) announced that Wu Cong applied to resign from the position of senior vice president and secretary of the board of directors for personal reasons, and would no longer hold any position in the company after resignation.

On February 9, Yibai Pharmaceutical (600594.SH) announced that Xu Miao applied to resign as deputy general manager and secretary of the board of directors for personal reasons. After his resignation, Xu Miao no longer holds any position in the company. Before the company formally appoints the new secretary of the board of directors, the board of directors of the company appoints Dou Yaqi, vice chairman and general manager of the company, to act as secretary of the board of directors.

On February 9, Dasenlin (603233.SH) announced that director Ke Kangbao applied to resign as a director of the company's fourth board of directors, and at the same time resigned as a member of the audit committee of the fourth board of directors and a member of the strategy committee of the fourth board of directors; Director Ke Jinlong applied to resign as a director of the company's fourth board of directors, and at the same time resigned as a member of the nomination committee of the fourth board of the board.